Louisville Hematology Highlights
Avatar

Summary of Recent Advances in the Management of MDS

By Louisville Hematology Highlights FEATURING Rami Komrokji
By Louisville Hematology Highlights FEATURING Rami Komrokji
143 views
February 26, 2024
Comments 0
Login to view comments. Click here to Login

Related Videos

25:03

ASH 2024 Summary: Highlights in AML, MDS, and ALL

2024 ASH Annual Meeting Insights Hub

T. Badar

1.4K views
21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

4.9K views
15:16

ASH 2024 Summary: Transplant Options and Outcomes for TP53 Myeloid D…

2024 ASH Annual Meeting Insights Hub

H. Fernandez

273 views
25:44

Myeloid Malignancies: Hot Topics in 2024

Yale Cancer Center

N. Podoltsev

427 views
27:49

AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024

Insights from 2024 EHA Annual Meeting

T. Badar

836 views
27:03

ASH 2024 Review: Updates on the Management of MDS

Cleveland Clinic Taussig Cancer Institute

H. Carraway

155 views
08:29

Debate: There Is a Role for Anti-Inflammatory Treatment in MDS

MDS Foundation

L. Weeks

115 views
13:18

Cellular Therapies for Myeloid Malignancies

Moffitt Cancer Center

D. Sallman

139 views
08:20

ASH 2024 Insights: Ven + HMA vs. HMA Alone in TP53m HR-MDS - Real-Wo…

2024 ASH Annual Meeting Insights Hub

T. Badar

115 views
14:32

Summary of Recent Updates in MDS

Vanderbilt University Medical Center (VUMC)

S. Ball

471 views
22:37

AML and MDS Highlights & Key Takeaways

Insights from 2023 ASH Annual Meeting

T. Badar

2.3K views
05:55

ASH 2024 Insights: Secondary Heme Malignancies in Myeloma Post-CAR-T…

2024 ASH Annual Meeting Insights Hub

J. Waldschmidt

112 views
31:53

HSCT in 2024: What Every Hematologist Needs to Know

Indy Hematology Review

R. Childs

891 views
23:04

Differentiation of CHIP, ICUS, CCUS, MDS, and VEXAS Syndrome

MyCancerHaven

R. Vij, S. Abedin

279 views
24:44

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

979 views
04:16

MDS and AML: Implementation of Guideline-Driven Germline Genetic Eva…

UChicago Medicine 12th International Clinical Cancer Genomics Conference

L. Banaszak

418 views
20:58

Defining Risk of Progression in CHIP/CCUS: A Pathologists' Perspecti…

16th International Congress on Myeloproliferative Neoplasms

R. Hasserjian

108 views
08:53

Debate: There Is Not a Role for Anti-Inflammatory Treatment in MDS

MDS Foundation

L. Adès

68 views
09:38

ASH 2024 Insights: Oral Decitabine-Cedazuridine in Pts With TP53mut …

2024 ASH Annual Meeting Insights Hub

S. Urrutia

48 views
13:26

Chronic GvHD: Main Complications After ASCT

Steven Pavletic

443 views
AUTOPLAY